Shanghai Fosun Pharmaceutical Co., Ltd.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is listed in filings as 10% Owner at Nature's Sunshine Products, Inc.. This profile follows SEC Form 4 activity through Jun 27, 2025, including sale activity. Recent filings connect the profile to Nature's Sunshine Products, Inc. (NATR). The current snapshot covers public activity from Oct 15, 2024 to Jun 27, 2025. Reported amounts are shown as $32.7M to $17.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.